Key Insights

Highlights

Treatment Research

2 treatments under study, led by Eo2002

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05636579Phase 1Recruiting

Study to Assess Safety and Tolerability of Multiple Doses of EO2002

Showing all 1 trials

Research Network

Common Treatments

  • Eo20021
  • Ripasudil1

Active Sponsors

  • Emmecell1
  • Asociación para Evitar la Ceguera en México1

Top Investigators

Related Conditions

  • Pseudophakic Bullous Keratopathy1
  • Bullous Keratopathy1
  • Endothelial Dysfunction1
  • Fuchs Dystrophy1
  • Fuchs Endothelial Dystrophy1

Activity Timeline